Sotera Health Announces Second-Quarter 2024 Earnings Release Date
Sotera Health Company (Nasdaq: SHC), a leading global provider of sterilization solutions and lab testing services for the healthcare industry, has announced its plans to release second-quarter 2024 financial results on Monday, August 5, 2024, before the market opens. The company will hold a conference call at 9:00 a.m. Eastern Time to discuss operating highlights and financial results.
To participate in the live call, investors can dial 1-844-481-2916 from the United States or 1-412-317-0709 from other locations. A live webcast of the conference call will be available on the company's website, along with accompanying materials. A replay of the webcast will be available later on the same day.
Sotera Health Company (Nasdaq: SHC), un fornitore globale leader di soluzioni di sterilizzazione e servizi di test di laboratorio per il settore sanitario, ha annunciato i suoi piani per pubblicare i risultati finanziari del secondo trimestre 2024 il lunedì 5 agosto 2024, prima dell'apertura del mercato. L'azienda terrà una conference call alle 9:00 a.m. Eastern Time per discutere i punti salienti operativi e i risultati finanziari.
Per partecipare alla chiamata dal vivo, gli investitori possono comporre il numero 1-844-481-2916 dagli Stati Uniti oppure 1-412-317-0709 da altre località. Una webcast dal vivo della conference call sarà disponibile sul sito web dell'azienda, insieme ai materiali correlati. Una registrazione della webcast sarà disponibile più tardi lo stesso giorno.
Sotera Health Company (Nasdaq: SHC), un proveedor global líder de soluciones de esterilización y servicios de pruebas de laboratorio para la industria de la salud, ha anunciado sus planes para publicar resultados financieros del segundo trimestre de 2024 el lunes 5 de agosto de 2024, antes de la apertura del mercado. La empresa realizará una conferencia telefónica a las 9:00 a.m. Eastern Time para discutir los aspectos destacados operativos y los resultados financieros.
Para participar en la llamada en vivo, los inversores pueden marcar 1-844-481-2916 desde los Estados Unidos o 1-412-317-0709 desde otras ubicaciones. Habrá una transmisión en vivo de la conferencia telefónica disponible en el sitio web de la empresa, junto con materiales complementarios. Una grabación de la transmisión estará disponible más tarde el mismo día.
소테라 헬스 컴퍼니(Nasdaq: SHC)는 의료 산업을 위한 멸균 솔루션 및 실험실 테스트 서비스의 글로벌 선두 제공업체로서 2024년 2분기 재무 결과를 2024년 8월 5일 월요일, 시장 개장 전에 발표할 계획임을 발표했습니다. 회사는 동부 표준시 오전 9시에 운영 하이라이트와 재무 결과에 대해 논의하기 위해 컨퍼런스 콜을 개최할 예정입니다.
실시간 통화에 참여하기 위해 투자자는 미국에서 1-844-481-2916로, 다른 지역에서는 1-412-317-0709로 전화할 수 있습니다. 회사 웹사이트에서 회의 통화의 실시간 웹캐스트와 함께 관련 자료를 사용할 수 있습니다. 같은 날 나중에 웹캐스트 재방송을 시청할 수 있습니다.
Sotera Health Company (Nasdaq: SHC), un fournisseur mondial de premier plan de solutions de stérilisation et de services d'essai de laboratoire pour l'industrie de la santé, a annoncé ses projets de publier les résultats financiers du deuxième trimestre 2024 le lundi 5 août 2024, avant l'ouverture des marchés. La société tiendra une conférence téléphonique à 9h00 heure de l'Est pour discuter des faits saillants opérationnels et des résultats financiers.
Pour participer à l'appel en direct, les investisseurs peuvent composer le 1-844-481-2916 depuis les États-Unis ou le 1-412-317-0709 depuis d'autres emplacements. Une diffusion en direct de la conférence téléphonique sera disponible sur le site Web de l'entreprise, accompagnée des documents connexes. Un enregistrement de la diffusion sera disponible plus tard dans la journée.
Sotera Health Company (Nasdaq: SHC), ein führender globaler Anbieter von Sterilisationslösungen und Labortests für die Gesundheitsindustrie, hat seine Pläne zur Veröffentlichung der Finanzergebnisse für das zweite Quartal 2024 am Montag, den 5. August 2024, vor der Markteröffnung bekannt gegeben. Das Unternehmen wird um 9:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um betriebliche Highlights und Finanzergebnisse zu besprechen.
Um an dem Live-Anruf teilzunehmen, können Anleger 1-844-481-2916 aus den Vereinigten Staaten oder 1-412-317-0709 aus anderen Regionen wählen. Eine Live-Übertragung der Telefonkonferenz wird auf der Unternehmenswebsite verfügbar sein, zusammen mit begleitenden Materialien. Eine Wiederholung der Übertragung wird später am selben Tag verfügbar sein.
- None.
- None.
CLEVELAND, July 22, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2024 before the market opens on Monday, August 5, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.
To participate in the live call, please dial 1-844-481-2916 if dialing-in from the United States, or 1-412-317-0709 if dialing-in from other locations. A live webcast of the conference call can be accessed at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health, along with the accompanying materials. A replay of the webcast will be available later in the day on August 5th.
Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health. For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health.
About Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
Contacts
Jason Peterson
Vice President & Treasurer, Sotera Health
IR@soterahealth.com
Kristin Gibbs
Chief Marketing Officer, Sotera Health
kgibbs@soterahealth.com
Source: Sotera Health Company
FAQ
When will Sotera Health (SHC) release its Q2 2024 earnings?
What time is Sotera Health's (SHC) Q2 2024 earnings call?
How can investors participate in Sotera Health's (SHC) Q2 2024 earnings call?
Where can I find Sotera Health's (SHC) Q2 2024 earnings materials?
